Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assessment of K-ras mutation: a step toward personalized medicine for patients with colorectal cancer.

Cancer - 15 Aug 2009

Jiang Yixing, Kimchi Eric T, Staveley-O'Carroll Kevin F, Cheng Hua, Ajani Jaffer A

Abstract excerpt

Some of the most significant therapeutic advances in the treatment of cancer have occurred in the management of colorectal metastases. The introduction of new cytotoxic chemotherapeutic and biologic agents has changed the approach to these patients from both an oncologic and a surgical perspective. In addition, an understanding of the molecular mechanisms by which these agents affect tumors is developing. This...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Colorectal Neoplasms
Share to Drug Delivery Systems

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Genes, ras

Share to Mutation

Share to Signal Transduction

Share to Treatment Outcome

Source

Identifiers

PMID: 19526592
DOI: 10.1002/cncr.24434

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Assessment of K-ras mutation: a step toward personalized medicine for patients with colorectal cancer.PMID 19526592Read ↗

K-ras mutations in colorectal cancer: a practice changing discovery.Semantic proximity Read ↗

Use of K-Ras as a predictive biomarker for selecting anti-EGF receptor/pathway treatment.Semantic proximity Read ↗

Epidermal growth factor receptor ligands: targets for optimizing treatment of metastatic colorectal cancer.Semantic proximity Read ↗

KRAS mutation testing of colorectal cancer for anti-EGFR therapy: dogmas versus evidence.Semantic proximity Read ↗

Personalized medicine and anti-EGFR antibody therapy in the treatment of metastatic colorectal cancer: KRAS and beyond.Semantic proximity Read ↗

RAS genes in colorectal carcinoma: pathogenesis, testing guidelines and treatment implicationsSemantic proximity Read ↗

[Clinical relevance of the K-ras oncogene in colorectal cancer: experience in a Mexican population].Semantic proximity Read ↗

Epidermal growth factor receptor pathway mutations and colorectal cancer therapy.Semantic proximity Read ↗

BRAF Mutations in Colorectal Cancer: Clinical Relevance and Role in Targeted TherapySemantic proximity Read ↗

Ras in digestive oncology: from molecular biology to clinical implications.Semantic proximity Read ↗

Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR.Semantic proximity Read ↗

The treatment of colorectal carcinoma with monoclonal antibodies: the importance of KRAS mutation analysis and EGFR status.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.